Development of LINAC-based neutron source for boron neutron capture therapy in university of Tsukuba

29Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Clinical trials of the boron neutron capture therapy (BNCT) have been conducted using research reactors. Recent progresses in the accelerator and accelerator-driven-neutron-source technologies have rendered it possible to generate the substantial number of neutrons required for BNCT treatment, using a compact accelerator, which can be installed in a hospital. The University of Tsukuba launched a project for the development of a compact accelerator-based neutron source for BNCT. For this accelerator, we employed a linear particle accelerator (linac) and the energy of the proton beam was 8 MeV. Beryllium was selected as the neutron target material. To generate sufficient neutron intensity by the reaction between 8MeV protons and beryllium, the linac accelerates a high current of 5mA or more. As the target system is critical, we developed a beryllium target system with a threelayered structure to avoid target breakage, caused by massive heat load and blistering, within a short period. The linac-based neutron source for the BNCT is almost complete and we succeeded in generating neutrons, in 2015. Currently, several characteristic measurements are being carried out.

Cite

CITATION STYLE

APA

Kumada, H., Naito, F., Hasegawa, K., Kobayashi, H., Kurihara, T., Takada, K., … Sakae, T. (2018). Development of LINAC-based neutron source for boron neutron capture therapy in university of Tsukuba. Plasma and Fusion Research, 13(1). https://doi.org/10.1585/pfr.13.2406006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free